H.R. 3839 · 118th Congress
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
- Stage
- In committee
- Sponsor
- Neal Dunn
- Introduced
- 2023-06-06
- Latest action
- 2023-06-09 · Referred to the Subcommittee on Health.
Subjects
Administrative law and regulatory procedures
Health
Department of Health and Human Services
Prescription drugs
Drug safety, medical device, and laboratory regulation